Syndax Pharmaceuticals, Inc. · NASDAQ:SNDX
Botwood Nicholas A.J. sold 65,515 Syndax Pharmaceuticals, Inc. shares (Form 4)
Traded Jun 11 to Jun 12, 2026 · Filed Jun 12, 2026
From Jun 11 to Jun 12, 2026, Botwood Nicholas A.J. (Head of R&D, CMO) sold 65,515 Syndax Pharmaceuticals, Inc. shares at an average US$18.07 for US$1.18M under a trading plan, leaving 60,885 shares. Filed Jun 12, 2026 (Form 4).
- Sold
- 65,515 shares
- Price
- US$18.07 average (US$18.00 to US$18.14)
- Value
- US$1.18M
- Holding after
- 60,885 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Head of R&D, CMO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 11, 2026 | Common Stock | Option exercise | 22,515 | US$13.82 | 95,165 | Direct |
| Jun 11, 2026 | Common Stock | Sale | 34,280 | US$18.00 | 60,885 | Direct |
| Jun 12, 2026 | Common Stock | Option exercise | 31,235 | US$13.82 | 92,120 | Direct |
| Jun 12, 2026 | Common Stock | Sale | 31,235 | US$18.14 | 60,885 | Direct |
Source
Related
- Syndax Pharmaceuticals, Inc.
- Botwood Nicholas A.J.
- Syndax Pharmaceuticals, Inc. shareholders
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Metzger Michael A · Jul 9, 2026
- Form 4 · Goldan Keith A. · Jun 2, 2026
- Form 4 · Metzger Michael A · Jun 2, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · May 15, 2026